Get the Stockscreener App
1.27
2.42%
0.03
After Hours:
1.27
Evogene Ltd stock is traded at $1.27, with a volume of 22,410.
It is up +2.42% in the last 24 hours and up +1.60% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
See More
Previous Close:
$1.24
Open:
$1.23
24h Volume:
22,410
Relative Volume:
0.01
Market Cap:
$11.18M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.3962
EPS:
-0.53
Net Cash Flow:
$-22.36M
1W Performance:
+5.57%
1M Performance:
+1.60%
6M Performance:
-9.29%
1Y Performance:
-54.80%
1-Day Range:
$1.2102
$1.2932
1-Week Range:
$1.21
$1.31
52-Week Range:
$0.95
$3.32
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.27 | 11.18M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene Partners with Google Cloud to Enhance AI-Driven Molecular Discovery - MSN
Can Evogene Ltd. Bounce Back From Weekly Low2025 Macro Impact & Free Weekly Watchlist of Top Performers - 뉴스영
Why Evogene Ltd. is moving today2025 Volume Leaders & Weekly Return Optimization Alerts - Newser
Automated trading signals detected on Evogene Ltd.Portfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Will Evogene Ltd. be affected by tariffsWeekly Investment Summary & AI Driven Stock Price Forecasts - خودرو بانک
Can Evogene Ltd. hit a new high this monthWeekly Market Report & Reliable Price Breakout Alerts - Newser
Key metrics from Evogene Ltd.’s quarterly dataTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
News impact scoring models applied to Evogene Ltd.July 2025 Levels & Community Trade Idea Sharing Platform - Newser
Is this a good reentry point in Evogene Ltd.2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
What’s next for Evogene Ltd. stock priceJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
What candlestick patterns are forming on Evogene Ltd.2025 Earnings Impact & Expert Approved Momentum Trade Ideas - Newser
Has Evogene Ltd. found a price floor2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Live market analysis of Evogene Ltd.July 2025 Earnings & Long Hold Capital Preservation Tips - Newser
Heatmap analysis for Evogene Ltd. and competitorsTrade Performance Summary & Consistent Income Trade Ideas - Newser
Evogene Ltd. stock momentum explainedOptions Play & Fast Gain Stock Trading Tips - Newser
Sector ETF performance correlation with Evogene Ltd.Trade Volume Summary & Consistent Profit Alerts - Newser
Signal strength of Evogene Ltd. stock in tech scanners2025 Performance Recap & Fast Entry High Yield Tips - Newser
Evogene Ltd. recovery potential after sell offRisk Management & Daily Profit Maximizing Tips - Newser
Should you wait for a breakout in Evogene Ltd.July 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Visualizing Evogene Ltd. stock with heatmapsQuarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Combining price and volume data for Evogene Ltd.Weekly Market Outlook & High Accuracy Buy Signal Tips - Newser
Building trade automation scripts for Evogene Ltd.2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
Is Evogene Ltd. trending in predictive chart modelsJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - Newser
Evogene Ltd. Earnings Call: Growth Amid Challenges - MSN
Can Evogene Ltd. maintain sales growthEarnings Trend Report & Accurate Intraday Trade Tips - خودرو بانک
What is Evogene Ltd.’s book value per shareJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Published on: 2025-09-02 10:11:25 - Newser
Tools to monitor Evogene Ltd. recovery probability2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Is Evogene Ltd. forming a breakout patternQuarterly Trade Report & Free Weekly Watchlist of Top Performers - خودرو بانک
Earnings visualization tools for Evogene Ltd.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Multi factor analysis applied to Evogene Ltd.2025 Technical Overview & Safe Entry Zone Identification - Newser
Intraday pattern recognizer results for Evogene Ltd.Earnings Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
Should you hold or exit Evogene Ltd. now2025 Valuation Update & Community Supported Trade Ideas - Newser
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):